|
| 34538638 | Aortic valve reintervention in patients with failing transcatheter aortic bioprostheses: A statewide experience. | J Thorac Cardiovasc Surg | 2023 |
| 37438029 | First-in-Human Multicenter Experience of the Newest Generation Supra-Annular Self-Expanding Evolut FX TAVR System. | JACC Cardiovasc Interv | 2023 |
| 37100557 | Redo Surgical Aortic Valve Replacement After Prior Transcatheter Versus Surgical Aortic Valve Replacement. | JACC Cardiovasc Interv | 2023 |
| 36697152 | The Relationship Between Hospital Stroke Center Designation and TVT Reported Stroke: The Michigan TAVR Experience. | JACC Cardiovasc Interv | 2023 |
| 35948202 | Outcomes in patients with electrocardiographic left ventricular dyssynchrony following transcatheter aortic valve replacement. | Heart Rhythm | 2023 |
| 35766258 | Multifaceted Intervention to Improve P2Y12 Inhibitor Adherence After Percutaneous Coronary Intervention: A Stepped Wedge Trial. | J Am Heart Assoc | 2022 |
| 34593108 | Transcatheter Aortic Valve Replacement with a Self-Expanding Prosthesis. | Interv Cardiol Clin | 2021 |
| 33719506 | Surgical Explantation of Transcatheter Aortic Valve Bioprostheses: A Statewide Experience. | Circ Cardiovasc Interv | 2021 |
| 31478304 | The initial U.S. experience with the Tempo active fixation temporary pacing lead in structural heart interventions. | Catheter Cardiovasc Interv | 2020 |
| 32839759 | Acute Myocardial Infarction and Papillary Muscle Rupture in the COVID-19 Era. | JACC Case Rep | 2020 |
| 31398357 | Early Structural Valve Degeneration of Trifecta Bioprosthesis. | Ann Thorac Surg | 2020 |
| 30448116 | Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Low-Gradient Aortic Stenosis. | JACC Cardiovasc Imaging | 2019 |
| 30144337 | Contemporary use of and outcomes associated with ultra-low contrast volume in patients undergoing percutaneous coronary interventions. | Catheter Cardiovasc Interv | 2019 |
| 31473239 | Outcomes of Veterans Undergoing TAVR Within Veterans Affairs Medical Centers: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. | JACC Cardiovasc Interv | 2019 |
| 31419621 | Expanding opportunities to understand quality and outcomes of peripheral vascular interventions: The ACC NCDR PVI Registry. | Am Heart J | 2019 |
| 30969440 | Atrioventricular conduction in patients undergoing pacemaker implant following self-expandable transcatheter aortic valve replacement. | Pacing Clin Electrophysiol | 2019 |
| 29289948 | Association of Anemia With Outcomes in Patients Undergoing Percutaneous Peripheral Vascular Intervention: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2 VIC). | J Invasive Cardiol | 2018 |
| 29518503 | Early Outcomes following Endovascular, Open Surgical, and Hybrid Revascularization for Lower Extremity Acute Limb Ischemia. | Ann Vasc Surg | 2018 |
| 29307456 | Impact of Annular Size on Outcomes After Surgical or Transcatheter Aortic Valve Replacement. | Ann Thorac Surg | 2018 |
| 29240607 | The Clinical Impact of Cardiology Consultation Prior to Major Vascular Surgery. | Ann Surg | 2018 |
| 28521921 | 1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical Bioprostheses. | JACC Cardiovasc Interv | 2017 |
| 28239949 | Temporal trends in peripheral arterial interventions: Observations from the blue cross blue shield of michigan cardiovascular consortium (BMC2 PVI). | Catheter Cardiovasc Interv | 2017 |
| 28370487 | Contrast-induced nephropathy in patients undergoing endovascular peripheral vascular intervention: Incidence, risk factors, and outcomes as observed in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. | J Interv Cardiol | 2017 |
| 28145612 | Coronary artery perforations after contemporary percutaneous coronary interventions: Evaluation of incidence, risk factors, outcomes, and predictors of mortality. | Catheter Cardiovasc Interv | 2017 |
| 29169498 | Heterogeneity of Ankle-Brachial Indices in Patients Undergoing Revascularization for Critical Limb Ischemia. | JACC Cardiovasc Interv | 2017 |
| 28930755 | VEGF and IGF Delivered from Alginate Hydrogels Promote Stable Perfusion Recovery in Ischemic Hind Limbs of Aged Mice and Young Rabbits. | J Vasc Res | 2017 |
| 27050187 | 3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement. | J Am Coll Cardiol | 2016 |
| 26584888 | Phase I study of multi-gene cell therapy in patients with peripheral artery disease. | Vasc Med | 2016 |
| 27835656 | The Association of Peri-Procedural Blood Transfusion with Morbidity and Mortality in Patients Undergoing Percutaneous Lower Extremity Vascular Interventions: Insights from BMC2 VIC. | PLoS One | 2016 |
| 27179735 | The optimal definition of contrast-induced acute kidney injury for prediction of inpatient mortality in patients undergoing percutaneous coronary interventions. | Am Heart J | 2016 |
| 26896357 | Psoas muscle size as a frailty measure for open and transcatheter aortic valve replacement. | J Thorac Cardiovasc Surg | 2016 |
| 25596978 | The association of perioperative transfusion with 30-day morbidity and mortality in patients undergoing major vascular surgery. | J Vasc Surg | 2015 |
| 26324153 | If not now, when? Prescription of evidence-based medical therapy prior to hospital discharge increases utilization at 6 months in patients with symptomatic peripheral artery disease. | Vasc Med | 2015 |
| 26210281 | Mortality Predictors in Patients Referred for but Not Undergoing Transcatheter Aortic Valve Replacement. | Am J Cardiol | 2015 |
| 24747101 | Impact of sex on morbidity and mortality rates after lower extremity interventions for peripheral arterial disease: observations from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. | J Am Coll Cardiol | 2014 |
| 25292418 | Contemporary outcomes with percutaneous vascular interventions for peripheral critical limb ischemia in those with and without poly-vascular disease. | Vasc Med | 2014 |
| 25323170 | Annulus instead of LVOT diameter improves agreement between echocardiography effective orifice area and invasive aortic valve area. | JACC Cardiovasc Imaging | 2014 |
| 23674313 | Contemporary use of prasugrel in clinical practice: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. | Circ Cardiovasc Qual Outcomes | 2013 |
| 23622915 | Current medical management of stable coronary artery disease before and after elective percutaneous coronary intervention. | Am Heart J | 2013 |
| 22607861 | The changing definition of contrast-induced nephropathy and its clinical implications: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). | Am Heart J | 2012 |
| 23233746 | The quality and impact of risk factor control in patients with stable claudication presenting for peripheral vascular interventions. | Circ Cardiovasc Interv | 2012 |
| 23022125 | Ankle-brachial index as a clinical tool. | Am J Med | 2012 |
| 21167341 | The association of sex with outcomes among patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction in the contemporary era: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). | Am Heart J | 2011 |
| 21700256 | Safety of contemporary percutaneous peripheral arterial interventions in the elderly insights from the BMC2 PVI (Blue Cross Blue Shield of Michigan Cardiovascular Consortium Peripheral Vascular Intervention) registry. | JACC Cardiovasc Interv | 2011 |
| 21502451 | Complication rates for percutaneous lower extremity arterial antegrade access. | Arch Surg | 2011 |
| 19953308 | Sustained release of multiple growth factors from injectable polymeric system as a novel therapeutic approach towards angiogenesis. | Pharm Res | 2010 |
| 21062999 | Defining the optimal degree of heparin anticoagulation for peripheral vascular interventions: insight from a large, regional, multicenter registry. | Circ Cardiovasc Interv | 2010 |
| 20187958 | Safety and efficacy of thrombectomy in patients undergoing primary percutaneous coronary intervention for acute ST elevation MI: a meta-analysis of randomized controlled trials. | BMC Cardiovasc Disord | 2010 |
| 19028778 | Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. | Eur Heart J | 2009 |
| 20031720 | A comparison of abciximab and small-molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials. | Circ Cardiovasc Interv | 2009 |